Omnicare, Inc. (OCR) Tops Q3 EPS by 2c, Posts FY11 Guidance
Tweet
Share
E-mailGet Alerts OCR Hot Sheet
Price: $97.90 --0%
Financial Fact:
Provision for doubtful accounts: 19.18M
Today's EPS Names:
MTEX, NSYS, PLNH, More
Financial Fact:
Provision for doubtful accounts: 19.18M
Today's EPS Names:
MTEX, NSYS, PLNH, More
Join SI Premium – FREE
Omnicare, Inc. (NYSE: OCR) reported Q3 EPS of $0.54, $0.02 better than the analyst estimate of $0.52. Revenue for the quarter came in at $1.54 billion versus the consensus estimate of $1.54 billion.
Omnicare, Inc. sees FY2011 EPS of $2.09-$2.13, versus the consensus of $2.11. Omnicare, Inc. sees FY2011 revenue of $6.-$6.1 billion, versus the consensus of $6.15 billion.
Omnicare, Inc. sees FY2011 EPS of $2.09-$2.13, versus the consensus of $2.11. Omnicare, Inc. sees FY2011 revenue of $6.-$6.1 billion, versus the consensus of $6.15 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Aptera Motors (SEV) Reports Q2 Loss of $0.20
- Acrivon Therapeutics, Inc. (ACRV) Tops Q2 EPS by 21c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
